melanoma

Castle boasts melanoma test’s capacity to reduce unnecessary testing
Clinical Trials Arena
Thu, 11/7/24 - 11:24 am
Medtech
diagnostics
Castle Biosciences
melanoma
DecisionDx-Melanoma
ESMO 2024: Regeneron’s melanoma combo therapy benefit continues beyond two years
Clinical Trials Arena
Mon, 09/16/24 - 09:46 am
ESMO
Regeneron
melanoma
clinical trials
fiablimab
BioNTech, Regeneron’s mRNA Cancer Vaccine Combo Clears Phase II in Melanoma
BioSpace
Tue, 07/30/24 - 11:41 am
BioNTech
Regeneron
Merck
Moderna Therapeutics
mRNA-4157/V940
melanoma
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters
Mon, 06/3/24 - 11:58 am
Moderna Therapeutics
Merck
skin cancer
melanoma
vaccines
Keytruda
ASCO: Bristol Myers unveils I-O triplet data in melanoma as Iovance touts ‘paradigm-changing’ combo result
Fierce Pharma
Thu, 05/23/24 - 09:46 pm
ASCO 2024
Bristol Myers Squibb
Iovance
melanoma
Opdualag
Yervoy
Merck stops testing combo drug for skin cancer as more patients discontinue
Reuters
Mon, 05/13/24 - 11:14 am
Merck
skin cancer
clinical trials
melanoma
vibostolimab
anti-TIGIT
Castle Biosciences reveals melanoma test study findings at SSO 2024
Clinical Trials Arena
Mon, 03/25/24 - 11:29 am
Castle Biosciences
DecisionDx-UM
melanoma
clinical trials
Pfizer's Braftovi to command 42% share of BRAF inhibitors melanoma market by 2028
Biopharma Reporter
Thu, 03/21/24 - 11:37 am
Pfizer
Braftovi
Roche
Zelboraf
melanoma
5 FDA Decisions to Watch in Q1
BioSpace
Tue, 01/2/24 - 11:24 am
FDA
Iovance Biotherapeutics
melanoma
lifileucel
Minerva Neurosciences
schizophrenia
roluperidone
Viatris
Mapi Pharma
MS
multiple sclerosis
GA Depot
Madrigal Pharmaceuticals
NASH
resmetirom
Vertex Pharmaceuticals
CRISPR Therapeutics
exa-cel
beta thalassemia
Moderna, Merck Cancer Vaccine-Keytruda Combo Gets Win at Three-Year Mark
BioSpace
Thu, 12/14/23 - 10:55 pm
Moderna Therapeutics
Merck
vaccines
Keytruda
melanoma
MRNA
5 Cancer Vaccines to Watch in 2024
BioSpace
Mon, 11/20/23 - 10:15 am
Merck
Moderna Therapeutics
melanoma
BioNTech
pancreatic cancer
OSE Immunotherapeutics
Transgene
non-small cell lung cancer
Nykode Therapeutics
cervical cancer
IO Biotech concludes subject enrollment in melanoma vaccine trial
Clinical Trials Arena
Mon, 11/13/23 - 09:57 am
IO Biotech
clinical trial
melanoma
vaccines
Cancer vaccine shows promising long-term survival data
Biopharma Reporter
Mon, 10/16/23 - 11:48 am
Ultimovacs
cancer vaccines
vaccines
melanoma
Bristol Myers Squibb's Opdivo reign expands with new earlier-stage melanoma nod
Fierce Pharma
Mon, 10/16/23 - 11:45 am
Bristol Myers Squibb
Opdivo
melanoma
FDA
Merck and Eisai's Keytruda-Lenvima combo chalks up 2 more losses, this time in non-small cell lung cancer
Fierce Pharma
Fri, 09/22/23 - 11:46 am
Merck
Eisai
Keytruda
Lenvima
melanoma
colorectal cancer
non-small cell lung cancer
FDA capacity forces delay to Iovance's cell therapy
Pharmaphorum
Fri, 09/15/23 - 11:47 am
Iovance Biotherapeutics
lifileucel
cell therapy
FDA
melanoma
Bristol Myers gets positive opinion from CHMP for Opdivo
Pharmaceutical Business Review
Mon, 07/24/23 - 10:20 am
Bristol Myers Squibb
Opdivo
CHMP
Europe
melanoma
Merck/Eisai Drops Melanoma Program for Keytruda-Lenvima Combo After Phase III Fail
BioSpace
Fri, 04/7/23 - 01:58 pm
Merck
Keytruda
Eisai
Lenvima
melanoma
clinical trials
cancer
colorectal cancer
Moderna’s experimental cancer vaccine treats but doesn’t prevent melanoma – a biochemist explains how it works
The Conversation
Wed, 01/18/23 - 09:44 am
Moderna Therapeutics
vaccines
cancer
melanoma
Moderna, Merck & Co. mRNA cancer vaccine slashes melanoma recurrence in Keytruda combo trial
Fierce Biotech
Tue, 12/13/22 - 10:35 am
Merck
Moderna Therapeutics
MRNA
cancer immunotherapy
Keytruda
melanoma

Pages